Al-Gully Jin, Oliveri Federico, Forouzanfar Jessica Parisa, Montero-Cabezas Jose Manuel, Jukema Johan Wouter, den Haan Melina Cynthia, Al Amri Ibtihal, Bingen Brian Oscar
Department of Cardiology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands.
Women's Heart Health Clinic, Leiden University Medical Center, Leiden, The Netherlands.
Open Heart. 2025 Jan 21;12(1):e003055. doi: 10.1136/openhrt-2024-003055.
Coronary microvascular disease (CMD) is defined as impaired coronary flow reserve (CFR) and/or increased microvascular resistance (MR) without significant epicardial coronary stenosis. This definition allows for discordant CFR and MR values within patients with CMD. The aim of this meta-analysis is to characterise the prognostic value and pathophysiological backgrounds of CFR and MR con-/discordance.
A systematic search (PROSPERO CRD42024573004) identified studies determining CFR and MR in patients without significant epicardial coronary artery disease. Patients were divided into four groups: (1) normal CFR and MR, (2) abnormal CFR and MR, (3) abnormal CFR with normal MR and (4) normal CFR with abnormal MR and analysed for all-cause mortality and major adverse cardiovascular events (MACE).
We identified four studies representing 2310 total participants. Group B had the highest MACE (OR: 3.23; 95% CI 1.95 to 5.36) and mortality rate (OR: 2.27; 95% CI 1.12 to 4.58) compared with group A. Group C, associated with female sex, showed significantly higher MACE (OR: 2.07; 95% CI 1.25 to 3.45) but not mortality (OR: 1.89; 95% CI 0.92 to 3.88) compared with group A. In group D, associated with high body mass index, MACE and mortality rates did not differ significantly from group A (OR: 1.19; 95% CI 0.67 to 2.11 and OR: 0.55; 95% CI 0.16 to 1.90, respectively).
Abnormal CFR and MR are associated with a high risk of MACE and death. Abnormal CFR and normal MR are associated with an increased MACE-but not death. MACE and mortality risk in discordantly normal CFR and abnormal MR are low. Our findings show the need for tailoring CFR and MR diagnostic thresholds to patient characteristics and raise questions about the presence of CMD in patients with abnormal MR with normal CFR.
冠状动脉微血管疾病(CMD)被定义为冠状动脉血流储备(CFR)受损和/或微血管阻力(MR)增加,而无明显的心外膜冠状动脉狭窄。这一定义允许CMD患者的CFR和MR值不一致。本荟萃分析的目的是描述CFR和MR一致/不一致的预后价值和病理生理背景。
一项系统检索(PROSPERO CRD42024573004)确定了在无明显心外膜冠状动脉疾病的患者中测定CFR和MR的研究。患者被分为四组:(1)CFR和MR正常,(2)CFR和MR异常,(3)CFR异常但MR正常,(4)CFR正常但MR异常,并分析全因死亡率和主要不良心血管事件(MACE)。
我们确定了四项研究,共纳入2310名参与者。与A组相比,B组的MACE发生率(比值比:3.23;95%置信区间1.95至5.36)和死亡率(比值比:2.27;95%置信区间1.12至4.58)最高。与女性相关的C组与A组相比,MACE发生率显著更高(比值比:2.07;95%置信区间1.25至3.45),但死亡率无显著差异(比值比:1.89;95%置信区间0.92至3.88)。与高体重指数相关的D组,MACE发生率和死亡率与A组无显著差异(分别为比值比:1.19;95%置信区间0.67至2.11和比值比:0.55;95%置信区间0.16至1.90)。
CFR和MR异常与MACE和死亡的高风险相关。CFR异常但MR正常与MACE增加相关,但与死亡无关。CFR正常但MR异常时,MACE和死亡风险较低。我们的数据表明,需要根据患者特征调整CFR和MR的诊断阈值,并对CFR正常但MR异常的患者是否存在CMD提出质疑。